Trading update and Notice of Results

Ideagen plc

(''Ideagen'' or the ''Company'')

Trading update and Notice of Results

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, issues the following update for the six month period to 31 October 2014.

Trading Update

Trading during the six month period continues to be robust with revenues and adjusted EBITDA* expected to show significant growth over the same period last year.

Revenues and adjusted EBITDA* have increased considerably due to the acquisitions of Pentana Ltd and EIBS Ltd combined with underlying organic growth** of approximately 10%.

Furthermore, the balance sheet remains robust with cash balances of £2.8 million (30 April 2014: £4.0 million), following the acquisition of EIBS Ltd in June plus associated costs.

The Company continues to trade in-line with market expectations for the full year to 30 April 2015.

Notice of Results

The interim results for the six months ended 31 October 2014 will be announced in the last week of January 2015.

David Hornsby, Chief Executive Officer, commented:

"We are pleased with the Company's progress, which has come through both acquisitive and organic growth. The momentum both in the period and since has been strong with, as announced, our largest single NHS contract to date and post period, being selected to provide Compliance and Quality Management Systems to NuGen. We look forward to the full year with confidence."

*earnings before interest, tax, depreciation, amortization, share based payments and acquisition costs.

** organic revenue growth on a pro-forma basis

Notes to Editors:

§ Ideagen is an Information Management software company specialising in:

‒ Governance, Risk and Compliance ('GRC')

‒ Clinical content solutions

§ The Group has established a global business supplying GRC solutions predominantly to the Healthcare, Complex Manufacturing, Banking and Finance and Energy Sectors.

§ Its Clinical content division has leveraged the Group's core technology and built a UK business supplying content and clinical management solutions to NHS Trusts and Private Healthcare providers.

§ Ideagen's global blue chip client base includes Siemens, Shell, BAE Systems and a range of NHS Trusts.

§ The Group listed on AIM in 2012 under the ticker IDEA.

§ For more information, please visit http://www.ideagenplc.com